Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
“Evaluation of the PillCam™ESO Capsule in the Detection of Esophageal Varices (MA-37)
This study has been completed.
Sponsors and Collaborators: Given Imaging Ltd.
Ethicon Endo-Surgery
Information provided by: Given Imaging Ltd.
ClinicalTrials.gov Identifier: NCT00481416
  Purpose

The purpose of the study is to access the accuracy of the PillCam Eso capsule in identifying the presence of suspected esophageal disease in patients undergoing surveillance or screening for esophageal disease by standard endoscopy


Condition Intervention
Esophageal Varices
Device: PillCam Eso

MedlinePlus related topics: Endoscopy Esophagus Disorders Varicose Veins
U.S. FDA Resources
Study Type: Observational
Study Design: Screening, Cross-Sectional, Defined Population, Prospective Study
Official Title: Evaluation of the PillCam™ Eso Capsule in the Detection of Esophageal Varices

Further study details as provided by Given Imaging Ltd.:

Enrollment: 318
Study Start Date: December 2004
Study Completion Date: January 2005
Detailed Description:

The procedure that is being evaluated in this study is an esophageal capsule which is part of the Given® Diagnostic System. This system has been developed for aiding the gastroenterologist in diagnosing small bowel diseases or disorders, as routine methods used today cannot explore the entire length of the small bowel in detail. It is currently available in more than 50 countries worldwide, including the Europe, USA, Canada, Central and South America, Australia and Asia. More than 300,000 capsules have already been ingested worldwide. In this study, a capsule developed and approved for the esophagus (food tube between the mouth and stomach) with two optical heads (mini cameras) will be used and intended to take better recorded pictures of the esophagus.

During the study the study participant will undergo a capsule endoscopy and an upper esophagoscopy. The method under investigation in this study is the capsule endoscopy.

The capsule endoscope is a small camera, about an inch long and less than half an inch wide, which you will be asked to swallow. The camera travels from a person’s mouth all the way through their stomach and intestines and is eventually passed in the stool. The camera has a light source (like a flash on a regular camera) and takes pictures of the esophagus. The pictures are sent to a recorder, about the size of a wallet, using electronic signals for 20 minutes while the wireless endoscope goes through your esophagus. The disposable capsule is passed in the stool in an average of 24 hours.

After the capsule endoscopy the study participant will undergo the esophagoscopy. An esophagoscopy is the standard method used to view the esophagus. It involves inserting a long flexible tube with a light and camera on the end (called an endoscope) through the mouth and down the throat and esophagus. It may also involve the use of a sedative.

The study involves approximately two-three clinic visits.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  1. Patient has prior endoscopic confirmation of esophageal varices and is undergoing surveillance endoscopy or
  2. Patient has sign/symptoms of chronic liver disease, without previous diagnosis of esophageal varices,with clinical indication to undergo esophagoscopy (or EGD)

Exclusion Criteria:

  1. Patient has difficulty swallowing
  2. Patient has known Zenker's Diverticulum
  3. Patient went through previous endoscopic treatment of esophageal varices
  4. Patient is known or is suspected to suffer from intestinal obstruction
  5. Patient has a cardiac pacemaker or other implanted electro medical device
  6. Female patient is pregnant
  7. Patient is expected to undergo MRI examination within 7 days after ingestion of the capsule
  8. Patient has had a prior abdominal surgery of the gastrointestinal tract (other than uncomplicated appendectomy or uncomplicated cholecystectomy)
  9. Patient has any condition, which precludes compliance with study and/or device instructions
  10. Patient suffers from life threatening conditions
  11. Patient is currently participating in another clinical study -
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00481416

Locations
United States, Arizona
Mayo Clinic Hospital
Scottsdale, Arizona, United States, 85259
United States, Minnesota
Minnesota Gastroenterology Associates
Plymouth, Minnesota, United States, 55446
United States, Oregon
Oregon Health Sciences University
Portland, Oregon, United States, 97239-3098
Australia, Queensland
Royal Brisbane and Women's Hospital
Herston, Queensland, Australia, 4029
Israel
Rambam Medical Center
Haifa, Israel
Sponsors and Collaborators
Given Imaging Ltd.
Ethicon Endo-Surgery
Investigators
Principal Investigator: Glenn M Eisen, MD OHSU Portland, OR
  More Information

Sponsor web site  This link exits the ClinicalTrials.gov site

Study ID Numbers: MA-37
Study First Received: May 30, 2007
Last Updated: May 30, 2007
ClinicalTrials.gov Identifier: NCT00481416  
Health Authority: United States: Institutional Review Board

Keywords provided by Given Imaging Ltd.:
Esophageal Varices
PillCam Eso
Capsule Endoscopy
Given Imaging
Inscope

Study placed in the following topic categories:
Esophageal varices
Liver Diseases
Digestive System Diseases
Esophageal disorder
Varicose Veins
Gastrointestinal Diseases
Vascular Diseases
Esophageal and Gastric Varices
Hypertension, Portal
Esophageal Diseases
Portal hypertension
Hypertension

Additional relevant MeSH terms:
Cardiovascular Diseases

ClinicalTrials.gov processed this record on January 13, 2009